Xiamen Amoytop Biotech Statistics

Total Valuation

Xiamen Amoytop Biotech has a market cap or net worth of CNY 30.86 billion. The enterprise value is 30.45 billion.

Market Cap	30.86B
Enterprise Value	30.45B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	May 23, 2024

Share Statistics

Xiamen Amoytop Biotech has 406.80 million shares outstanding. The number of shares has increased by 0.55% in one year.

Shares Outstanding	406.80M
Shares Change (YoY)	+0.55%
Shares Change (QoQ)	+1.62%
Owned by Insiders (%)	50.86%
Owned by Institutions (%)	13.36%
Float	110.49M

Valuation Ratios

The trailing PE ratio is 46.85 and the forward PE ratio is 34.26. Xiamen Amoytop Biotech's PEG ratio is 1.14.

PE Ratio	46.85
Forward PE	34.26
PS Ratio	12.91
PB Ratio	15.32
P/FCF Ratio	115.55
PEG Ratio	1.14

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.36, with an EV/FCF ratio of 114.00.

EV / Earnings	46.30
EV / Sales	12.76
EV / EBITDA	36.36
EV / EBIT	39.50
EV / FCF	114.00

Financial Position

The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.01.

Current Ratio	4.07
Quick Ratio	3.14
Debt / Equity	0.01
Debt / EBITDA	0.01
Debt / FCF	0.04
Interest Coverage	1,586.05

Financial Efficiency

Return on equity (ROE) is 37.18% and return on invested capital (ROIC) is 27.08%.

Return on Equity (ROE)	37.18%
Return on Assets (ROA)	22.57%
Return on Capital (ROIC)	27.08%
Revenue Per Employee	1.13M
Profits Per Employee	312,257
Employee Count	1,960
Asset Turnover	1.12
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.39% in the last 52 weeks. The beta is 0.45, so Xiamen Amoytop Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+98.39%
50-Day Moving Average	56.09
200-Day Moving Average	56.83
Relative Strength Index (RSI)	78.95
Average Volume (20 Days)	2,930,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Xiamen Amoytop Biotech had revenue of CNY 2.39 billion and earned 657.61 million in profits. Earnings per share was 1.62.

Revenue	2.39B
Gross Profit	2.23B
Operating Income	770.76M
Pretax Income	759.60M
Net Income	657.61M
EBITDA	831.52M
EBIT	770.76M
Earnings Per Share (EPS)	1.62

Full Income Statement

Balance Sheet

The company has 424.77 million in cash and 10.20 million in debt, giving a net cash position of 414.57 million or 1.02 per share.

Cash & Cash Equivalents	424.77M
Total Debt	10.20M
Net Cash	414.57M
Net Cash Per Share	1.02
Equity (Book Value)	2.01B
Book Value Per Share	4.95
Working Capital	968.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 533.85 million and capital expenditures -266.78 million, giving a free cash flow of 267.07 million.

Operating Cash Flow	533.85M
Capital Expenditures	-266.78M
Free Cash Flow	267.07M
FCF Per Share	0.66

Full Cash Flow Statement

Margins

Gross margin is 93.31%, with operating and profit margins of 32.30% and 27.55%.

Gross Margin	93.31%
Operating Margin	32.30%
Pretax Margin	31.83%
Profit Margin	27.55%
EBITDA Margin	34.84%
EBIT Margin	32.30%
FCF Margin	11.19%

Dividends & Yields

This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 0.51%.

Dividend Per Share	0.41
Dividend Yield	0.51%
Dividend Growth (YoY)	92.49%
Years of Dividend Growth	4
Payout Ratio	25.36%
Buyback Yield	-0.55%
Shareholder Yield	-0.05%
Earnings Yield	2.13%
FCF Yield	0.87%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xiamen Amoytop Biotech has an Altman Z-Score of 33.89.

Altman Z-Score	33.89
Piotroski F-Score	n/a